Home Cart 0 Sign in  

[ CAS No. 22353-40-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 22353-40-8
Chemical Structure| 22353-40-8
Structure of 22353-40-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 22353-40-8 ]

Related Doc. of [ 22353-40-8 ]

Alternatived Products of [ 22353-40-8 ]

Product Details of [ 22353-40-8 ]

CAS No. :22353-40-8 MDL No. :MFCD03840432
Formula : C5H2Cl2N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :XLPDVAVQKGDHNO-UHFFFAOYSA-N
M.W : 192.99 Pubchem ID :2763106
Synonyms :

Calculated chemistry of [ 22353-40-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.08
TPSA : 58.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.34
Log Po/w (XLOGP3) : 2.31
Log Po/w (WLOGP) : 2.3
Log Po/w (MLOGP) : 0.49
Log Po/w (SILICOS-IT) : 0.59
Consensus Log Po/w : 1.4

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.83
Solubility : 0.286 mg/ml ; 0.00148 mol/l
Class : Soluble
Log S (Ali) : -3.18
Solubility : 0.127 mg/ml ; 0.000659 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.64
Solubility : 0.441 mg/ml ; 0.00229 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.09

Safety of [ 22353-40-8 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P261-P280-P301+P310-P305+P351+P338 UN#:2923
Hazard Statements:H301-H315-H318-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 22353-40-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 22353-40-8 ]
  • Downstream synthetic route of [ 22353-40-8 ]

[ 22353-40-8 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 22353-40-8 ]
  • [ 97966-00-2 ]
Reference: [1] Patent: US2004/242641, 2004, A1,
  • 2
  • [ 22353-38-4 ]
  • [ 22353-40-8 ]
YieldReaction ConditionsOperation in experiment
97% at 0 - 120℃; for 2 h; Inert atmosphere Quinoline (48.5 ml, 0.41 mol) was added to POCl3 (164.0 ml, 1.75 mol) at 0 C under nitrogen. To this stirred mixture, 2-hydroxy- 3-chloro-5-nitropyridine (204 mg, 1.17 mol) was added. The reaction mixturewas heated at 120 C for 2 h, cooled to 0 C followed by addition of ice-cold water. The precipitate obtained was filtered, washed thoroughly with water and dried to give 2,3-dichloro-5- nitropyridine. Yield: 220 g, (97percent). M.P.: 53 C. 1H NMR (300 MHz, DMSO-d6): d 9.16 (d, 1H, J ¼ 2.4 Hz), 8.94 (d, 1H, J ¼ 2.4 Hz). 13C NMR (300 MHz, DMSO-d6): d 158.69, 137.36, 132.51, 130.13, 124.39. MS (ES): 193 (M þ 1).
70.3% at 0 - 120℃; for 2 h; Inert atmosphere Quinoline (0.3 mL, 2.34 mmol) was added to POCl3(0.5 mL 4.68 mmol) at 0 °C under nitrogen. To this stirred mixture was added 2-hydroxy-3-chloro-5-nitro pyridine (816 mg, 4.68 mmol) (product obtained in step i) The reaction mixture was heated at 120 °C for 2 hours, cooled to 0 °C followed by addition of ice cold water. The precipitate obtained was filtered, washed with water and dried to obtain 2,3-dichloro-5-nitro pyridine. Yield: 630 mg (70.3 percent); m.p.: 53 °C; *H NMR (DMSO-d6) δ: 8.94 (d, 1H, J = 2.5 Hz), 9.16 (d, 1H, J = 2.5 Hz).
70.3% at 0 - 120℃; for 2 h; Inert atmosphere Quinoline (0.3 mL, 2.34 mmol) was added to POCl3 (0.5 mL 4.68 mmol) at 0 °C under nitrogen. To this stirred mixture was added 2-hydroxy-3-chloro-5-nitropyridine (816 mg, 4.68 mmol) obtained in step a. The reaction mixture was heated at 120 °C for 2 h, and was cooled to 0 °C followed by addition of ice-cold water. The precipitate obtained was filtered, washed with water and dried to obtain 2,3-dichloro-5-nitropyridine. Yield: 70.3 percent; *H NMR (DMSO-d6): δ 9.16 (d, J=1.8HZ, 1H), 8.60 (d, J=1.8Hz, 1H); MS (ES): m/z 193 (M+l).
Reference: [1] Synthesis, 1990, # 6, p. 499 - 501
[2] European Journal of Medicinal Chemistry, 2012, vol. 58, p. 355 - 360
[3] Patent: WO2013/117963, 2013, A1, . Location in patent: Page/Page column 21
[4] Patent: WO2014/207508, 2014, A1, . Location in patent: Page/Page column 55
[5] Roczniki Chemii, 1968, vol. 42, p. 2079,2084[6] Chem.Abstr., 1969, vol. 70, p. 106327
[7] Yakugaku Zasshi, 1952, vol. 72, p. 378,380[8] Chem.Abstr., 1953, p. 6403
[9] Journal of Scientific and Industrial Research, 1962, vol. 21 B, p. 483,486
[10] Patent: WO2004/50637, 2004, A2, . Location in patent: Page 66-67
[11] Patent: US2004/242644, 2004, A1, . Location in patent: Page 4
[12] Patent: US2006/35937, 2006, A1, . Location in patent: Page/Page column 10
[13] Patent: US2003/114457, 2003, A1,
[14] Patent: US5922732, 1999, A,
[15] Patent: US2005/261348, 2005, A1,
[16] Patent: WO2008/35306, 2008, A1, . Location in patent: Page/Page column 24
[17] Patent: WO2007/53394, 2007, A1, . Location in patent: Page/Page column 12-13
[18] Patent: US2004/242641, 2004, A1, . Location in patent: Page 4
[19] Patent: WO2008/35306, 2008, A1, . Location in patent: Page/Page column 24
  • 3
  • [ 22353-38-4 ]
  • [ 7732-18-5 ]
  • [ 22353-40-8 ]
YieldReaction ConditionsOperation in experiment
89% With trichlorophosphate In quinoline To phosphorus oxychloride (37.4 mL, 0.4 mol) at 0° C. was added quinoline (23.6 mL, 0.2 mol), followed by 3-chloro-2-hydroxy-5-nitropyridine (70 g, 0.4 mol) from above.
The mixture was heated at 120° C. for 2.5 hours, during which time it became a dark liquid.
After cooling to 100° C., H2 O (150 mL) was added cautiously, and the mixture was cooled to 0° C.
The precipitated solid was collected by filtration, washed with cold H2 O, and dried under vacuum at 50° C. to afford 2,3-dichloro-5-nitropyridine (68.6 g, 89percent).
Reference: [1] Patent: US6133253, 2000, A,
  • 4
  • [ 5418-51-9 ]
  • [ 22353-40-8 ]
Reference: [1] Synthesis, 1990, # 6, p. 499 - 501
[2] Yakugaku Zasshi, 1952, vol. 72, p. 378,380[3] Chem.Abstr., 1953, p. 6403
[4] Patent: WO2006/88920, 2006, A1, . Location in patent: Page/Page column 112
[5] European Journal of Medicinal Chemistry, 2012, vol. 58, p. 355 - 360
[6] Patent: WO2013/117963, 2013, A1,
[7] Patent: WO2014/207508, 2014, A1,
[8] Patent: US2004/242641, 2004, A1,
  • 5
  • [ 22353-38-4 ]
  • [ 10025-87-3 ]
  • [ 22353-40-8 ]
Reference: [1] Patent: US6432880, 2002, B1,
  • 6
  • [ 89-73-6 ]
  • [ 22353-40-8 ]
  • [ 59-49-4 ]
  • [ 22353-38-4 ]
YieldReaction ConditionsOperation in experiment
89% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18 h; General procedure: To a solution of N-hydroxysalicylamide (0.5 g, 3.26 mmol) in anhydrous DMF (5 ml) was added 2a or 2b (3.26 mmol) and freshly calcinated K2CO3 (1.35 g, 9.78 mmol) and the mixture was kept, with stirring at the room temperature overnight. DMF was removed in vacuo and the residue was treated with water (10 ml) and then extracted with CH2Cl2 (5 ml). The organic layer was separated, washed with water, dried over anhydrous CaCl2, and purified by flesh chromatography on silica gel using CH2Cl2 as eluent. Dichloromethane was evaporated in vacuo. The resulting residue was benzo[d]oxazol-2(3H)-one 11. The water layer was acidify by hydrochloric acid, filtered and washed with water. The resulting residue was compound 12a(b).
Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 52, p. 5877 - 5880
  • 7
  • [ 22353-40-8 ]
  • [ 22353-38-4 ]
Reference: [1] Patent: US1778784, 1928, ,
  • 8
  • [ 22353-40-8 ]
  • [ 124-41-4 ]
  • [ 22353-53-3 ]
YieldReaction ConditionsOperation in experiment
45.8 mg at 20℃; for 1.5 h; Sodium methoxide (5M methanol solution) (0.5 ml) was added to a methanol (1 ml) solution of 2,3-dichloro-5-nitropyridine (50 mg), followed by stirring at room temperature for 1.5 hours.
Water was added, followed by extraction with ethyl acetate.
The resultant was washed with saturated saline and dried over anhydrous sodium sulfate, the solvent was distilled away under reduced pressure, and colorless oily matter of 3-chloro-2-methoxy-5-nitropyridine (45.8 mg) was thus obtained.
Reference: [1] Patent: EP2589592, 2018, B1, . Location in patent: Paragraph 1105; 1106
  • 9
  • [ 22353-40-8 ]
  • [ 13061-96-6 ]
  • [ 51984-62-4 ]
YieldReaction ConditionsOperation in experiment
344 mg With tetrakis(triphenylphosphine) palladium(0); caesium carbonate In 1,4-dioxane at 100℃; for 6 h; Cesium carbonate (338 mg), methylboronic acid (47 mg), and tetrakis(triphenylphosphine)palladium (60 mg) were added to a 1,4-dioxane (3 ml) solution containing 2,3-dichloro-5-nitropyridine (100 mg), followed by stirring at 100°C for 6 hours.
The reaction solution was adjusted to room temperature, and water was added, followed by extraction with ethyl acetate.
The resultant was washed with saturated saline and dried over anhydrous sodium sulfate, the solvent was distilled away under reduced pressure, and 3-chloro-2-methyl-5-nitropyridine (344 mg) was thus obtained.
Reference: [1] Patent: EP2589592, 2018, B1, . Location in patent: Paragraph 1190; 1191
  • 10
  • [ 22353-40-8 ]
  • [ 98121-41-6 ]
Reference: [1] Synthesis, 1990, # 6, p. 499 - 501
[2] Patent: US2004/242644, 2004, A1, . Location in patent: Page 4
[3] Patent: US2005/261348, 2005, A1,
[4] Tetrahedron Letters, 2013, vol. 54, # 19, p. 2303 - 2307
[5] Patent: US2004/242641, 2004, A1, . Location in patent: Page 4
  • 11
  • [ 22353-40-8 ]
  • [ 7439-89-6 ]
  • [ 98121-41-6 ]
YieldReaction ConditionsOperation in experiment
85% With magnesium sulfate In water; acetic acid; ethyl acetate EXAMPLE 10
3-amino-5,6-dichloropyridine
77.2 g (0.4 mol) of 2,3-dichloro-5-nitropyridine were dissolved in 135 ml of glacial acetic acid, and 800 ml of water were added with stirring. 111.7 g (2 mol) of iron powder were introduced in portions into the mixture (temperature<=50° C.).
After completion of the reaction, the mixture is filtered under suction and the product extracted using ethyl acetate.
The organic phase was washed with water until neutral, dried using MgSO4 and concentrated by evaporation.
The product was recrystallized from toluene.
Yield 85percent Melting point 107° C.
Reference: [1] Patent: US4756739, 1988, A,
[2] Patent: US5922732, 1999, A,
  • 12
  • [ 22353-40-8 ]
  • [ 7732-18-5 ]
  • [ 98121-41-6 ]
Reference: [1] Patent: US6133253, 2000, A,
  • 13
  • [ 22353-40-8 ]
  • [ 110860-92-9 ]
Reference: [1] Synthesis, 1990, # 6, p. 499 - 501
[2] Tetrahedron Letters, 2013, vol. 54, # 19, p. 2303 - 2307
  • 14
  • [ 22353-40-8 ]
  • [ 488713-31-1 ]
Reference: [1] Patent: EP2975031, 2016, A1,
[2] Patent: EP3192791, 2017, A1,
  • 15
  • [ 22353-40-8 ]
  • [ 488713-30-0 ]
YieldReaction ConditionsOperation in experiment
32.8%
Stage #1: at 200℃; for 1 h; Microwave irradiation
Stage #2: With hydrogenchloride; iron(III) chloride hexahydrate In 1-methyl-pyrrolidin-2-one at 20℃; for 0.666667 h;
A mixture of 2,3-dichloro-5-nitropyridine (15.24 g, 78.97 mmol) and copper cyanide (28.3 g, 315.88 mmol) in NMP (128 mL) was stirred under microwave irradiation at 200°C for 1 hr.
The reaction mixture was added to 0.5 N HCl (1300 mL) and iron(III) chloride 6 hydrate (107 g, 394.84 mmol), and the mixture was stirred at room temperature for 40 min and extracted with ethyl acetate/hexane mixed solution (3:1).
The organic layer was washed with water and brine, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (solvent gradient; 2→10percent ethyl acetate/hexane) to give 3-chloro-5-nitropicolinonitrile (4.76 g, 25.9 mmol, 32.8percent) as a pale-yellow solid.
NMR (300 MHz, CDCl3):δ 8.68(1H,d,J=2.3 Hz), 9.40(1H,d,J=2.3 Hz).
Reference: [1] Patent: EP3192791, 2017, A1, . Location in patent: Paragraph 0506
  • 16
  • [ 22353-40-8 ]
  • [ 488713-30-0 ]
Reference: [1] Patent: EP2975031, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 22353-40-8 ]

Chlorides

Chemical Structure| 55304-72-8

[ 55304-72-8 ]

2,3,6-Trichloro-5-nitropyridine

Similarity: 0.86

Chemical Structure| 4548-45-2

[ 4548-45-2 ]

2-Chloro-5-nitropyridine

Similarity: 0.83

Chemical Structure| 98121-41-6

[ 98121-41-6 ]

3-Amino-5,6-dichloropyridine

Similarity: 0.80

Chemical Structure| 4487-56-3

[ 4487-56-3 ]

2,4-Dichloro-5-nitropyridine

Similarity: 0.80

Chemical Structure| 51984-62-4

[ 51984-62-4 ]

3-Chloro-2-methyl-5-nitropyridine

Similarity: 0.78

Nitroes

Chemical Structure| 55304-72-8

[ 55304-72-8 ]

2,3,6-Trichloro-5-nitropyridine

Similarity: 0.86

Chemical Structure| 4548-45-2

[ 4548-45-2 ]

2-Chloro-5-nitropyridine

Similarity: 0.83

Chemical Structure| 4487-56-3

[ 4487-56-3 ]

2,4-Dichloro-5-nitropyridine

Similarity: 0.80

Chemical Structure| 51984-62-4

[ 51984-62-4 ]

3-Chloro-2-methyl-5-nitropyridine

Similarity: 0.78

Chemical Structure| 22280-60-0

[ 22280-60-0 ]

6-Chloro-2-methyl-3-nitropyridine

Similarity: 0.77

Related Parent Nucleus of
[ 22353-40-8 ]

Pyridines

Chemical Structure| 55304-72-8

[ 55304-72-8 ]

2,3,6-Trichloro-5-nitropyridine

Similarity: 0.86

Chemical Structure| 4548-45-2

[ 4548-45-2 ]

2-Chloro-5-nitropyridine

Similarity: 0.83

Chemical Structure| 98121-41-6

[ 98121-41-6 ]

3-Amino-5,6-dichloropyridine

Similarity: 0.80

Chemical Structure| 4487-56-3

[ 4487-56-3 ]

2,4-Dichloro-5-nitropyridine

Similarity: 0.80

Chemical Structure| 51984-62-4

[ 51984-62-4 ]

3-Chloro-2-methyl-5-nitropyridine

Similarity: 0.78